Update on Over-the-Counter (OTC) Contraceptio...

POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. Author Satish Raj, MD, MSCI, of University of Calgary Cumming School of Medicine joins JAMA Deputy Editor Kr ...  Show more

Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen Holt, MD, MS, of Yale School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss first-line pharmacotherapy for al ...  Show more

Soon you can buy them all at your local drugstore. The FDA approved an over-the-counter birth control pill that will be available later this month. Journalist Lux Alptraum and Megan Kavanaugh of the Guttmacher Institute explain why available doesn’t necessarily mean more accessib ...  Show more

This week we discuss the FDA’s approval of the first over-the-counter oral contraceptive! It’s exciting news that will expand access to women’s reproductive care. We also talk about how excited we are for Yin on Fire, a recent trip to Chicago, and fall coming soon. 

Ple ...

FDA Advisory Board Approves First Over-the-Counter Birth Control Pill

This week an FDA advisory board <a href="https://www ...

Last week, for the first time in U.S. history, federal regulators approved the sale of a birth control pill without a prescription.

Pam Belluck, a health and science correspondent for The Times, explains why, after decades of brutal battles over contraception, this decis ...